In Lab, SLU Researchers Find Benefits for Diabetes, Fatty Liver Disease When Combining Two Anti-Diabetes Drugs

A Saint Louis University research team, led by Kyle S. McCommis, Ph.D., assistant professor in Biochemistry and Molecular Biology, found that combining two classes of anti-diabetes drugs provides superior benefits in mouse models of diabetes and fatty liver disease. Read more…